Works matching IS 03090167 AND DT 2022 AND VI 81 AND IP 4
Results: 15
Evidence‐levels in pathology for informing the WHO classification of tumours.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 420, doi. 10.1111/his.14648
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 419, doi. 10.1111/his.14413
- Publication type:
- Article
Corrigendum to "Pancreatic hamartoma: detection of harbouring NAB2::STAT6 fusion gene".
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 540, doi. 10.1111/his.14782
- Publication type:
- Article
Prostatic malakoplakia: clinicopathological assessment of a multi‐institutional series of 49 patients.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 520, doi. 10.1111/his.14729
- By:
- Publication type:
- Article
What's new in WHO fifth edition – urinary tract.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 439, doi. 10.1111/his.14764
- By:
- Publication type:
- Article
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 511, doi. 10.1111/his.14728
- By:
- Publication type:
- Article
Histopathological risk factors for malignancy in dermatomyositis.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 529, doi. 10.1111/his.14727
- By:
- Publication type:
- Article
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 447, doi. 10.1111/his.14711
- By:
- Publication type:
- Article
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 496, doi. 10.1111/his.14726
- By:
- Publication type:
- Article
Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR).
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 467, doi. 10.1111/his.14725
- By:
- Publication type:
- Article
Uterine tumours with myogenic differentiation harbouring SRF::RELA fusions.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 477, doi. 10.1111/his.14724
- By:
- Publication type:
- Article
Clinicopathologic features of an MXI1::NUTM1 fusion neoplasm; a new molecular variant of the family of NUTM1‐rearranged neoplasm.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 536, doi. 10.1111/his.14720
- By:
- Publication type:
- Article
WHO 2022 landscape of papillary and chromophobe renal cell carcinoma.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 426, doi. 10.1111/his.14700
- By:
- Publication type:
- Article
An introduction to the WHO 5th edition 2022 classification of testicular tumours.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 459, doi. 10.1111/his.14675
- By:
- Publication type:
- Article
IgG4‐related disease is characterised by the overexpression of immunomodulatory proteins.
- Published in:
- Histopathology, 2022, v. 81, n. 4, p. 486, doi. 10.1111/his.14564
- By:
- Publication type:
- Article